ReviewCurrent treatment options in cardiovascular medicine2019

Risk of Cardiomyopathy in Breast Cancer: How Can We Attenuate the Risk of Heart Failure from Anthracyclines and Anti-HER2 Therapies?

Gretchen Kimmick et al.PubMed ↗Publisher ↗

No numbers read from the abstract.